Molecular and Cellular Biochemistry

, Volume 342, Issue 1–2, pp 183–190 | Cite as

Altered expression of pro- and anti-inflammatory cytokines is associated with reduced cardiac function in rats following coronary microembolization

  • Lang Li
  • Xianming Zhao
  • Yongguang Lu
  • Weiqiang Huang
  • Weiming Wen
Article

Abstract

Coronary microembolization (CME) is a spontaneous event in patients with ischemic heart disease and a potential iatrogenic complication in patients undergoing coronary interventions. CME induces an obvious inflammatory reaction, characterized by cellular infiltration, particularly of eosinophils, and multifocal microinfarcts. However, little is known on the correlation between pro- and anti-inflammatory cytokines and cardiac function following CME. In this study, microspheres with a diameter of 42 μm were intracoronarily injected into the apex of the left ventricle to induce CME (CME group). Rats injected with normal saline served as controls (sham operated control group). Expression of pro-inflammatory cytokines, TNF-α and IL-1β, and an anti-inflammatory cytokine, IL-10, was measured at 3, 6, 12, 24 h, and 4 weeks post-injection by reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry. At the same time points, cardiac function and histological changes were evaluated by echocardiographic imagining and H&E staining, respectively. It was observed that the mRNA and protein expressions of TNF-α, IL-1β, and IL-10 all started to increase at 3 h, reached to the peak levels at 12 h, and returned to the normal levels at 4 weeks post-injection. The left ventricular ejection fraction (LVEF) was significantly lower in the CME group than in the control group at 3, 6, 12, 24 h, and 4 weeks post-injection. Obvious myocardial microinfarcts with surrounding myocardial edema and degeneration, caryolysis, and infiltration of neutrophils and monocytes were observed in the CME group at 3, 6, 12, 24 h, and 4 weeks post-injection. Moreover, mRNA expression of TNF-α and IL-1β was negatively correlated with LVEF, although not with myocardial microinfarcts, in the CME group. It is concluded that both protein and mRNA expression of TNF-α IL-1β and IL-10 are dynamically changed following CME, which is associated with reduced cardiac function. Therefore, these cytokines may be potential therapeutic targets for clinical treatment of CME.

Keywords

Coronary microembolization TNF-α IL-1β IL-10 Cardiac function Myocardial microinfarcts 

References

  1. 1.
    Erbel R, Heusch G (2000) Coronary microembolization. J Am Coll Cardiol 36:22–24CrossRefPubMedGoogle Scholar
  2. 2.
    Heusch G, Schulz R, Haude M, Erbel R (2004) Coronary microembolization. J Mol Cell Cardiol 37:23–31CrossRefPubMedGoogle Scholar
  3. 3.
    Ottani F, Galvani M, Ferrini D, Sorbello F, Limonetti P, Pantoli D, Rusticali F (1995) Prodromal angina limits infarct size. A role for ischemic preconditioning. Circulation 91:291–297PubMedGoogle Scholar
  4. 4.
    Davies MJ, Thomas AC, Knapman PA, Hangartner JR (1986) Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 73:418–427PubMedGoogle Scholar
  5. 5.
    Arras M, Strasser R, Mohri M, Doll R, Eckert P, Schaper W, Schaper J (1998) Tumor necrosis factor-alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine. Basic Res Cardiol 93:97–107CrossRefPubMedGoogle Scholar
  6. 6.
    Frangogiannis NG (2006) Targeting the inflammatory response in healing myocardial infarcts. Curr Med Chem 13:1877–1893CrossRefPubMedGoogle Scholar
  7. 7.
    D’Orazio TJ, Niederkorn JY (1998) A novel role of TGF-B and IL-10 in the induction of immune privilege. J Immunol 160:2089–2098PubMedGoogle Scholar
  8. 8.
    Li L, Elliott JF, Mosmann TR (1994) IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J Immunol 153:3967–3978PubMedGoogle Scholar
  9. 9.
    He KL, Dickstein M, Sabbah HN, Yi GH, Gu A, Maurer M, Wei CM, Wang J, Burkhoff D (2004) Mechanisms of heart failure with well preserved ejection fraction in dogs following limited coronary microembolization. Cardiovasc Res 64:9–11CrossRefGoogle Scholar
  10. 10.
    Kalenikova EI, Gorodetskaya EA, Zacharova NV, Shechter AB, Medvedev OS (1998) Perindopril effects on angiotensin I elimination in lung after experimental myocardial injury induced by intracoronary microembolization in rats. J Cardiovasc Pharmacol 32:608–615CrossRefPubMedGoogle Scholar
  11. 11.
    Schiller NB, Acquatella H, Ports TA, Drew D, Goerke J, Ringertz H, Silverman NH, Brundage B, Botvinick EH, Boswell R, Carlsson E, Parmley WW (1979) Left ventricular volume from paired biplane two-dimensional echocardiography. Circulation 60:547–555PubMedGoogle Scholar
  12. 12.
    Lie JT, Holley KE, Kampa WR, Titus JL (1971) New histochemical method for morphologic diagnosis of early stages of myocardial ischemia. Mayo Clin Proc 46:319–327PubMedGoogle Scholar
  13. 13.
    Thielmann M, Dörge H, Martin C, Belosjorow S, Schwanke U, van De Sand A, Konietzka I, Büchert A, Krüger A, Schulz R, Heusch G (2002) Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-alpha, and sphingosine. Circ Res 90:807–813CrossRefPubMedGoogle Scholar
  14. 14.
    Gössl M, Malyarm NM, Rosol M, Beighley PE, Ritman EL (2003) Impact of coronary vasa vasorum functional structure on coronary vessel wall perfusion distribution. Am J Physiol Heart Circ Physiol 285:H2019–H2026PubMedGoogle Scholar
  15. 15.
    Skyschally A, Schulz R, Erbel R, Heusch G (2002) Reduced coronary and inotropic reserves with coronary microembolization. Am J Physiol Heart Circ Physiol 282:H611–H614PubMedGoogle Scholar
  16. 16.
    Skyschally A, Gres P, Heusch P, Martin C, Haude M, Erbel R, Schulz R, Heusch G (2005) Preinfarction angina: no interference of coronary microembolization with acute ischemic preconditioning. J Mol Cell Cardiol 39:355–361CrossRefPubMedGoogle Scholar
  17. 17.
    Torre-Amione G, Kapadin S, Benediet C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 27:1201–1206CrossRefPubMedGoogle Scholar
  18. 18.
    Munger M, Johnson B, Amber IJ, Callahan KS, Gilbert EM (1996) Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure, secondary to ischemic of idiopathic dilated cardiomyopathy. Am J Cardiol 77:723–727CrossRefPubMedGoogle Scholar
  19. 19.
    Aukrust P, Ueland T, Lien E, Bendtzen K, Müller F, Andreassen AK, Nordøy I, Aass H, Espevik T, Simonsen S, Frøland SS, Gullestad L (1999) Cytokines network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 83:376–382CrossRefPubMedGoogle Scholar
  20. 20.
    Dörge H, Schulz R, Belosjorow S, Post H, van de Sand A, Konietzka I, Frede S, Hartung T, Vinten-Johansen J, Youker KA, Entman ML, Erbel R, Heusch G (2002) Coronary microembolization: the role of TNFa in contractile dysfunction. J Mol Cell Cardiol 34:51–62CrossRefPubMedGoogle Scholar
  21. 21.
    Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Malefyt R, Roncarolo MG (2001) IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 166:5530–5539PubMedGoogle Scholar
  22. 22.
    Li WM, Liu W, Gao C, Zhou BG, Yang SS, Wang Z, Zhang RH, Gan RT, Kong YH, Li Y (2006) IL-10 gene modified dendritic cells induced antigen-specific tolerance in experimental autoimmune myocarditis. Clin Immunol 121:63–73CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2010

Authors and Affiliations

  • Lang Li
    • 1
  • Xianming Zhao
    • 1
  • Yongguang Lu
    • 1
  • Weiqiang Huang
    • 1
  • Weiming Wen
    • 1
  1. 1.Department of CardiologyThe First Affiliated Hospital of Guangxi Medical UniversityNanningChina

Personalised recommendations